AdvanSix Inc. operates as a global manufacturer and supplier of polymer resins, serving markets across the United States and internationally. A key offering is Nylon 6, a versatile synthetic polymer resin utilized in the production of fibers, filaments, specialized plastics, and films. The company's portfolio also includes caprolactam, an essential building block for other polymer resins, and ammonium sulfate fertilizers, which it distributes to farm cooperatives, retailers, and other channel partners. Furthermore, AdvanSix supplies acetone, a crucial ingredient for manufacturing adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins. Its extensive range additionally comprises various intermediate chemicals, such as phenol, alpha-methyl styrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide. These offerings are marketed under established brands like Aegis, Capra, Sulf-N, Nadone, Naxol, and EZ-Blox. AdvanSix utilizes a dual sales approach, engaging directly with customers while also leveraging a network of distributors. The company, established in 2016, is headquartered in Parsippany, New Jersey.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.52B | $1.53B | $1.95B | $1.68B | $1.16B | $1.30B | $1.51B | $1.48B |
| Cost of Revenue | $1.36B | $1.37B | $1.63B | $1.41B | $1.02B | $1.16B | $1.34B | $1.25B |
| Gross Profit | $152.94M | $165.09M | $314.48M | $274.12M | $133.75M | $135.47M | $174.49M | $226.18M |
| Gross Margin | 10.08% | 10.76% | 16.16% | 16.27% | 11.55% | 10.44% | 11.52% | 15.33% |
| Operating Expenses | $94.02M | $95.54M | $87.75M | $82.98M | $133.75M | $75.38M | $81.22M | $72.81M |
| Operating Income | $58.91M | $69.55M | $226.73M | $191.14M | N/A | $60.10M | $93.26M | $153.37M |
| Operating Margin | 3.88% | 4.54% | 11.65% | 11.35% | 0.00% | 4.63% | 6.16% | 10.40% |
| Net Income | $44.15M | $54.62M | $171.89M | $139.79M | $46.08M | $41.35M | $66.24M | $146.70M |
| Net Margin | 2.91% | 3.56% | 8.83% | 8.30% | 3.98% | 3.19% | 4.37% | 9.94% |
| EPS (Basic) | $1.65 | $2.00 | $6.15 | $4.97 | $1.64 | $1.47 | $2.20 | $4.81 |
| EBITDA | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Stock Option Compensation Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Earnings Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Sales Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Capitalization | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |